CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 74 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $447,426 | -33.0% | 4,049,102 | +0.1% | 0.00% | – |
| Q3 2022 | $668,000 | -38.3% | 4,046,755 | -5.7% | 0.00% | – |
| Q2 2022 | $1,082,000 | -52.6% | 4,292,163 | 0.0% | 0.00% | – |
| Q1 2022 | $2,282,000 | -31.4% | 4,292,163 | -20.6% | 0.00% | – |
| Q4 2021 | $3,328,000 | -40.3% | 5,404,260 | -1.1% | 0.00% | – |
| Q3 2021 | $5,575,000 | -44.2% | 5,466,841 | +0.1% | 0.00% | – |
| Q2 2021 | $9,996,000 | +33.4% | 5,462,050 | +43.6% | 0.00% | – |
| Q1 2021 | $7,493,000 | +61.5% | 3,803,777 | +2.5% | 0.00% | – |
| Q4 2020 | $4,640,000 | -37.5% | 3,711,852 | -9.9% | 0.00% | – |
| Q3 2020 | $7,419,000 | -75.2% | 4,121,873 | +15.5% | 0.00% | -100.0% |
| Q2 2020 | $29,955,000 | +60.8% | 3,570,198 | +0.4% | 0.00% | 0.0% |
| Q1 2020 | $18,629,000 | +5.9% | 3,555,102 | +10.4% | 0.00% | 0.0% |
| Q4 2019 | $17,587,000 | +15.0% | 3,221,097 | +2.5% | 0.00% | 0.0% |
| Q3 2019 | $15,298,000 | -28.3% | 3,141,301 | +2.0% | 0.00% | 0.0% |
| Q2 2019 | $21,346,000 | +7.4% | 3,080,166 | +7.7% | 0.00% | 0.0% |
| Q1 2019 | $19,874,000 | +37.7% | 2,859,541 | +15.7% | 0.00% | 0.0% |
| Q4 2018 | $14,436,000 | -20.0% | 2,471,833 | +3.4% | 0.00% | 0.0% |
| Q3 2018 | $18,045,000 | +50.2% | 2,390,014 | +0.5% | 0.00% | 0.0% |
| Q2 2018 | $12,011,000 | -8.9% | 2,378,405 | +10.0% | 0.00% | 0.0% |
| Q1 2018 | $13,184,000 | -13.3% | 2,161,309 | +0.9% | 0.00% | 0.0% |
| Q4 2017 | $15,209,000 | +23.4% | 2,142,153 | +24.3% | 0.00% | 0.0% |
| Q3 2017 | $12,323,000 | +25.1% | 1,723,420 | +10.2% | 0.00% | – |
| Q2 2017 | $9,850,000 | -4.9% | 1,563,408 | +24.5% | 0.00% | -100.0% |
| Q1 2017 | $10,357,000 | +3.5% | 1,255,429 | +6.0% | 0.00% | 0.0% |
| Q4 2016 | $10,005,000 | +23.8% | 1,184,010 | -0.5% | 0.00% | – |
| Q3 2016 | $8,084,000 | +312.9% | 1,190,506 | +81.8% | 0.00% | – |
| Q2 2016 | $1,958,000 | +122.8% | 654,901 | +34.9% | 0.00% | – |
| Q1 2016 | $879,000 | +20.7% | 485,579 | +10.1% | 0.00% | – |
| Q4 2015 | $728,000 | -99.5% | 441,159 | -91.7% | 0.00% | -100.0% |
| Q3 2015 | $159,757,000 | +15440.6% | 5,285,443 | +1483.8% | 0.01% | – |
| Q2 2015 | $1,028,000 | – | 333,713 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |